TY - JOUR
T1 - Advancing Metastatic Spine Tumor Research
T2 - A Review of AO Spine Knowledge Forum Tumor’s Scientific Contributions Derived From the EPOSO Network, 2014-2024
AU - on the behalf of the AO Spine Knowledge Forum Tumor
AU - Rutges, Joost P.H.J.
AU - Zuckerman, Scott L.
AU - Arnold, Paul M.
AU - Bettegowda, Chetan
AU - Boriani, Stefano
AU - Clarke, Michelle J.
AU - Fehlings, Michael G.
AU - Ziya L Gokaslan, L Gokaslan
AU - Lazary, Aron
AU - Rhines, Laurence D.
AU - Sahgal, Arjun
AU - Sciubba, Daniel M.
AU - Schuster, James M.
AU - Weber, Michael H.
AU - Laufer, Ilya
AU - Fisher, Charles G.
N1 - Dr. Rutges receives honorarium of AO spine for educational activities. Dr Rutges is orthopedics officer for the Dutch AO Spine Council. Dr Rutges received a research grant from the AO Spine Knowledge forum Tumor. Dr Zuckerman reports being an unaffiliated neurotrauma consultant for the National Football League and Medtronic. Dr Bettegowda receives consulting fees from Haystack Oncology, Privo Technoloy and Bionaut Labs. Dr Bettegowda is Co-founder of OrisDx and Belay Diagnostics. Dr Boriani is a member of the AO Spine Knowledge forum Tumor Advisory board. Dr Gokaslan received funding for research and support for attending meetings and/or travel from the AO Spine Knowledge forum Tumor. Dr Rhines receives consulting fees, honorarium and support for attending meetings and/or travel from Stryker, Icotec and AO Spine. Dr Sahgal receives research Grants from Elekta AB, Varian, Seagen Inc an BrainLAB. Dr Shgal receives consulting fees from Varian, Elekta (Gamma Knife Icon) and BrainLAB. Dr Shgal receives honorarium from AstraZenica, Elekta AB, Varian, BrainLAB, Saegen Inc, Cerapedics, Carbo Fix and Servier. Dr Sahgal receives support for attending meetings and/or travel fromElekta, Varian and BrainLAB. Dr Sahgal has a planned, issued or pending Patent on a System for automated and Quantative Assessment of Metastatic Spinal Stability. Dr Sahgal is a member of the advisory board of Elekta and chair of the Elekta Gamma Knife Icon group. Dr Saghal is the President of the International Stereotactic Radiosurgery Society (ISRS). Dr Sciubba receives consulting fees from Medtronic, Depuy-Synthes, Stryker, Nuvasive, Pacira and Baxter. Dr Sciubba is a member of AO North America Board and an AANS/CNS Spine Executive Committee member. Dr Sciubba has stock or stock options from Augmedics and Biophy. Dr Weber receives research grants from Mitacs, CIHR, Depuy. RSBO and the Canadian Cancer Society. Dr Weber is a member of the AO Spine North America Education Committee. Dr Laufer receives royalties from Globus and consulting fees from Icotec and Depuy/Synthes. Dr Laufer receives support for attending meetings and/or travel from AO Spine. Dr Fisher receives royalties from Medtronic and consulting fees from Medtronic and Nuvasive. Dr Fisher receives institutional support for spine fellowships from AO Spine, Medtronic and Depuy/Synthes.
PY - 2025/3/12
Y1 - 2025/3/12
N2 - Study Design: Narrative Review. Objectives: To summarize the work of the AO Spine Knowledge Forum Tumor, specifically studies from the Epidemiology, Process and Outcomes in Spine Oncology (EPOSO) study. Methods: A narrative review of all published manuscripts from the EPOSO study was undertaken. EPOSO represents a multicenter, prospective registry effort across 10 North American and European sites to enroll patients with metastatic disease of the spine. Results: The current review summarized all studies from the EPOSO network, divided into the following five sections: (1) quality of life and satisfaction, (2) overall survival, (3) spinal instability, (4) neurologic outcome in patients with metastatic epidural spinal cord compression or radicular pain, and (5) patient and tumor-specific factors. Several important findings were elucidated. Patient evaluation should include SINS, nutritional status, severity and duration of neurologic deficit, extent of metastatic tumor burden, and differentiation of axial from radicular pain. Moreover, SOSGOQ2.0 serves as a useful and validated instrument for patient-reported outcome instrument. Despite the palliative nature of metastatic spine surgery, clear improvement in quality-of-life is seen. Even in patients with short-survival, the remaining weeks and months of life result in improved quality-of-life. Metastatic spine surgery often improves neurologic function, potentially enhancing survival through increased performance status. Conclusions: Several noteworthy results have come from the EPOSO network, highlighting important trends in metastatic spine care. The AO Spine Knowledge Forum Tumor has helped advancing metastatic spine tumor research as well as ensure these new findings reach and benefit clinicians and their patients.
AB - Study Design: Narrative Review. Objectives: To summarize the work of the AO Spine Knowledge Forum Tumor, specifically studies from the Epidemiology, Process and Outcomes in Spine Oncology (EPOSO) study. Methods: A narrative review of all published manuscripts from the EPOSO study was undertaken. EPOSO represents a multicenter, prospective registry effort across 10 North American and European sites to enroll patients with metastatic disease of the spine. Results: The current review summarized all studies from the EPOSO network, divided into the following five sections: (1) quality of life and satisfaction, (2) overall survival, (3) spinal instability, (4) neurologic outcome in patients with metastatic epidural spinal cord compression or radicular pain, and (5) patient and tumor-specific factors. Several important findings were elucidated. Patient evaluation should include SINS, nutritional status, severity and duration of neurologic deficit, extent of metastatic tumor burden, and differentiation of axial from radicular pain. Moreover, SOSGOQ2.0 serves as a useful and validated instrument for patient-reported outcome instrument. Despite the palliative nature of metastatic spine surgery, clear improvement in quality-of-life is seen. Even in patients with short-survival, the remaining weeks and months of life result in improved quality-of-life. Metastatic spine surgery often improves neurologic function, potentially enhancing survival through increased performance status. Conclusions: Several noteworthy results have come from the EPOSO network, highlighting important trends in metastatic spine care. The AO Spine Knowledge Forum Tumor has helped advancing metastatic spine tumor research as well as ensure these new findings reach and benefit clinicians and their patients.
KW - metastases
KW - oncology
KW - spine
KW - tumor
UR - https://www.scopus.com/pages/publications/105000821375
UR - https://www.scopus.com/pages/publications/105000821375#tab=citedBy
U2 - 10.1177/21925682251326515
DO - 10.1177/21925682251326515
M3 - Review article
C2 - 40074676
AN - SCOPUS:105000821375
SN - 2192-5682
VL - 15
SP - 2999
EP - 3006
JO - Global Spine Journal
JF - Global Spine Journal
IS - 6
ER -